Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Universal ResourcesFinancial_Report.xls
10-Q - QUARTERLY REPORT - Universal Resourcesv329023_10q.htm
EX-32.2 - CERTIFICATION - Universal Resourcesv329023_ex32-2.htm
EX-31.1 - CERTIFICATION - Universal Resourcesv329023_ex31-1.htm
EX-31.2 - CERTIFICATION - Universal Resourcesv329023_ex31-2.htm

 

Exhibit 32.1

 

Chief Executive Officer Certification (Section 906)

 

CERTIFICATION PURSUANT TO

18 U.S.C., SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), I, the undersigned Chief Executive Officer of Global Immune Technologies, Inc., (the “Company”), herby certify that, to the best of my knowledge, the Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2012 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. A signed original of this written statement required by Section 906 has been provided to the registrant and will be retained by it and furnished to the Securities and Exchange Commission or its staff upon request.

 

Dated: November 20, 2012

 

  Global Immune Technologies, Inc.
   
  /s/ Serge Talon
  Serge Talon
  President & CEO